Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Using the drugs AMD3100 and Tacrolimus together greatly improves skin healing and hair growth after a deep skin cut by increasing stem cells in the wound.

Wnt and Notch pathways are crucial for repairing blood stem cells after damage.

Stem cells control their future role by changing ERK signal timing, affecting tissue regeneration and cancer.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Feline cutaneous lymphocytosis is likely reactive, while canine cutaneous lymphocytosis needs more study to understand its nature.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

The conclusion is that CD90 is not a specific marker for fibroblast subtypes and better methods are needed to identify them.

TLR2 is crucial for hair growth and regeneration, and boosting it can help prevent hair loss.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

Bipotent dermal stem cells and specific macrophages are crucial for hair regrowth and regeneration.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Skin stem cells in hair follicles are important for touch sensation.

Toluene diisocyanate exposure can cause immune sensitization by interacting with proteins in hair follicles and sebaceous glands.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Mouse hair follicle stem cells lose their ability to change into different cell types after being grown for a long time.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Activating certain hair follicle cells could prevent hair loss from cancer treatments.

Alopecia areata patients have lower SOX9 and CD34 levels, affecting hair growth.

BST2 is a key marker for hair loss disease alopecia areata.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

A specific group of early-stage melanocytes is reduced in vitiligo-affected skin, which may explain treatment resistance.

IL-15 promotes hair growth and protects hair follicles.